zraviv06 | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

About:

Website
Details

Posts by :

June 2, 2013 Akt inhibition for cancer treatment, where do we stand today?
June 1, 2013 FDA approved two drugs and a companion diagnostic test for the treatment of advanced or unresectable cutaneous melanoma patients
May 22, 2013 Soft Tissue Sarcoma: an Overview
May 9, 2013 The Development of siRNA-Based Therapies for Cancer
April 23, 2013 Whole exome somatic mutations analysis of malignant melanoma contributes to the development of personalized cancer therapy for this disease
April 6, 2013 Targeting Mitochondrial-bound Hexokinase for Cancer Therapy
March 25, 2013 Cancer Screening at Sourasky Medical Center Cancer Prevention Center in Tel-Aviv
March 16, 2013 A P(hD)aradox
March 7, 2013 The Importance of Cancer Prevention Programs: New Percpectives for Fighting Cancer

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,071 other followers

Email Address:
Recent Posts
- The top 10 medtech M&A deals of 2020 April 14, 2021
- Mechanism of Thrombosis with AstraZeneca and J & J Vaccines: Expert Opinion by Kate Chander Chiang & Ajay Gupta, MD April 14, 2021
- Fighting Chaos with Care, community trust, engagement must be cornerstones of pandemic response April 13, 2021
- Linking Thrombotic Thrombocytopenia to ChAdOx1 nCov-19 Vaccination, AstraZeneca April 12, 2021
- Cryo-EM disclosed how the D614G mutation changes SARS-CoV-2 spike protein structure. April 10, 2021
- Embryogenesis in Mechanical Womb April 8, 2021
- COVID-19 Sequel: Neurological Impact of Social isolation been linked to poorer physical and mental health March 30, 2021
- T cells recognize recent SARS-CoV-2 variants March 30, 2021
- Top Industrialization Challenges of Gene Therapy Manufacturing March 29, 2021
- COVID-related financial losses at Mass General Brigham March 28, 2021
Archives
Archives
Categories
Categories
Meta